AS01B,ipilimumab,nivolumab
bms
[]
present at #sitc22 annual meeting in boston, ma today to present our research on intratumoral administration of myeloid dendritic cells (mydc) in the rapid oral abstract session (session 206) and on our poster (#790)! 